Glimpses of Hope for Lebrikizumab in Asthma

(MedPage Today) -- PHOENIX -- Exacerbation-prone asthma patients who had high blood eosinophil counts or elevated fractional exhaled nitric oxide (FeNO) appeared to benefit from lebrikizumab, pooled data from two disappointing phase III trials...
Source: MedPage Today Allergy - Category: Allergy & Immunology Source Type: news